37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ring chromosomes are structural aberrations commonly associated with birth defects, mental disabilities, and growth retardation 1, 2 . Rings form upon fusion of the long and short arms of a chromosome, sometimes associated with large terminal deletions 2 . Due to the severity of these large-scale aberrations affecting multiple contiguous genes, no possible therapeutic strategies for ring chromosome disorders have so far been proposed. During cell division ring chromosomes can exhibit unstable behavior, leading to continuous production of aneuploid progeny with low viability and high cellular death rate 3- 9 . The overall consequences of this chromosomal instability have been largely unexplored in experimental model systems. Here we generated human induced pluripotent stem cells (iPSCs) 10- 12 from patient fibroblasts containing ring chromosomes with large deletions and found that reprogrammed cells lost the abnormal chromosome and duplicated the wild type homologue via the compensatory uniparental disomy (UPD) mechanism. The karyotypically normal iPSCs with isodisomy for the corrected chromosome outcompeted co-existing aneuploid populations, allowing rapid and efficient isolation of patient-derived iPSCs devoid of the original chromosomal aberration. Our results suggest a fundamentally different function of cellular reprogramming as a means of “chromosome therapy” 13 to reverse combined loss-of-function across many genes in cells with large-scale aberrations involving ring structures. In addition, our work provides an experimentally tractable human cellular model system for studying mechanisms of chromosomal number control, which is of critical relevance to human development and disease.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Reprogramming of human somatic cells to pluripotency with defined factors.

          Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Association between microdeletion and microduplication at 16p11.2 and autism.

            Autism spectrum disorder is a heritable developmental disorder in which chromosomal abnormalities are thought to play a role. As a first component of a genomewide association study of families from the Autism Genetic Resource Exchange (AGRE), we used two novel algorithms to search for recurrent copy-number variations in genotype data from 751 multiplex families with autism. Specific recurrent de novo events were further evaluated in clinical-testing data from Children's Hospital Boston and in a large population study in Iceland. Among the AGRE families, we observed five instances of a de novo deletion of 593 kb on chromosome 16p11.2. Using comparative genomic hybridization, we observed the identical deletion in 5 of 512 children referred to Children's Hospital Boston for developmental delay, mental retardation, or suspected autism spectrum disorder, as well as in 3 of 299 persons with autism in an Icelandic population; the deletion was also carried by 2 of 18,834 unscreened Icelandic control subjects. The reciprocal duplication of this region occurred in 7 affected persons in AGRE families and 4 of the 512 children from Children's Hospital Boston. The duplication also appeared to be a high-penetrance risk factor. We have identified a novel, recurrent microdeletion and a reciprocal microduplication that carry substantial susceptibility to autism and appear to account for approximately 1% of cases. We did not identify other regions with similar aggregations of large de novo mutations. Copyright 2008 Massachusetts Medical Society.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              R: A Lenguage and Environment for Statisctical Computing

                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                6 May 2014
                12 January 2014
                6 March 2014
                06 September 2014
                : 507
                : 7490
                : 99-103
                Affiliations
                [1 ]Institute for Human Genetics and Department of Pediatrics, University of California San Francisco (UCSF), CA, USA
                [2 ]Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco (UCSF), CA, USA
                [3 ]Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA
                [4 ]Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA, USA
                [5 ]Department of Psychiatry, Institute for Human Genetics, UCSF, CA, USA
                [6 ]Department of Medicine, Division of Endocrinology and Metabolism and Institute for Human Genetics, CA, UCSF
                [7 ]Department of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA
                [8 ]Department of Reprogramming Science, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
                [9 ]Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland OH, USA
                Author notes
                [# ]corresponding authors: Anthony Wynshaw-Boris: ajw168@ 123456case.edu , Shinya Yamanaka: syamanaka@ 123456gladstone.ucsf.edu
                [*]

                these authors contributed equally

                Article
                NIHMS545399
                10.1038/nature12923
                4030630
                24413397
                0af1cd7b-5bce-4cf3-bcbc-d13d2641ae3d

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article